Director of regulatory and public policy development at US Pharmacopeia.
Senior advisor on policy and advocacy for Project Hope.
AMA J Ethics. 2024 Jun 1;26(6):E472-478. doi: 10.1001/amajethics.2024.472.
Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients' health and safety, especially in low- and middle-income regions. This article discusses consequences and risks of antimicrobial resistance and other ways in which antimicrobial medicines can be of poor quality and recommends regulatory and policy reforms to help maintain supply chain resilience and quality of antimicrobial medicines.
劣质抗菌药物继续在供应链中泛滥，威胁患者的健康和安全，特别是在中低收入地区。本文讨论了抗菌药物耐药性的后果和风险，以及抗菌药物质量可能变差的其他方式，并建议进行监管和政策改革，以帮助维持供应链的弹性和抗菌药物的质量。
